← Back to DTIL

Precision BioSciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 03/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 03/11/2025Jun 2024Filed 03/11/2025Mar 2024Filed 03/11/2025
$0$11$0$0$0$0.6$50$18
−$33−$18−$22−$24−$21−$16$33$8.6
−$1.26−$0.75−$1.84−$2.13−$2.21−$2.25$4.67$1.70
262512119.37.375.1

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.